Home
Search results “M d anderson cancer information homepage”
Look for the Lapel Pin
 
01:01
Community Hospitals North and East are affiliated with MD Anderson Cancer Network™, a program of The University of Texas MD Anderson Cancer Center. Our collaboration with MD Anderson provides cancer patients in Central Indiana with exclusive access to the nation's top experts, treatments and guidelines in cancer care. Patients should keep an eye out for MD Anderson Cancer Center certified physicians who now wear the lapel pins featured in this video. For more information, visit our website: http://www.ecommunity.com/cancercare/
Prof. Nathan Fowler: Long-term follow-up of lenalidomide + rituximab in iNHL – ICML 2017
 
04:04
ICML, 14-17 June 2017, Lugano, Switzerland Prof. Nathan Fowler The University of Texas MD Anderson Cancer Center, Houston, TX, US For more information about ICML 2017: http://www.lymphomahub.com/medical-information/categories//page/1/10/keyword/ICML For more information on our LymphomaHub Website visit: http://www.lymphomahub.com/ For more information about Prof. Nathan Fowler’s PubMed page visit: https://www.ncbi.nlm.nih.gov/pubmed/?term=Fowler%20NH%5BAuthor%5D&cauthor=true&cauthor_uid=28482717 For more information on The University of Texas MD Anderson Cancer Center, visit: https://www.mdanderson.org/
Views: 348 Lymphoma Hub
TEXAS CANCER CENTRE MINI documentary
 
13:01
As we establish our Medical intitution,we would like to take you back in the days and keep you posted about the progress of Texas Cancer Centre,for more information kindly contact us through our website http://www.texascancercentre.co.ke/ Facebook link https://www.facebook.com/cancerinkenya/?ref=br_rs
Views: 479 Opipi Mixmasters
Chemotherapy and Children with Hodgkin's Lymphoma - Anas Younes MD
 
03:03
For more information on Hodgkin's Lymphoma, visit http://www.mdanderson.org/patient-and-cancer-information/cancer-information/cancer-types/hodgkins-disease/ Anas Younes, M.D., with the department of lymphoma and myeloma at M. D. Anderson Cancer Center discusses issues associated the side effects of Hodgkin's lymphoma treatments like Chemotherapy on young patients, and the research being done right now to ease those side effects.
The Cutting Edge of Cancer Treatment - Hitachi
 
01:14
In Houston, TX , the MD Anderson Cancer Center uses Hitachi’s innovative Proton Beam Therapy to precisely target tumors with protons, help over 5,000 patients fight cancer to date. With this safer, more effective treatment, Hitachi is helping make the future bright for patients around the world. Related website:http://www.hitachi.us/about/hitachi/infographics/
Views: 1238 HitachiBrandChannel
How venetoclax (ABT-199) targets and kills CLL cells
 
01:53
Dr William Wierda from the University of Texas MD Anderson Cancer Center, Houston, TX explains how the drug venetoclax (ABT-199) targets and kills chronic lymphocytic leukemia (CLL) cells. Venetoclax inhibits Bcl-2, which is present at high levels in CLL cells, and it is responsible for the prolonged survival of these cells. Venetoclax will block and decrease the activity of Bcl-2. Visit our website | http://www.patientpower.eu/ Follow on Twitter | https://twitter.com/patientpowereu Like on Facebook | https://www.fb.com/patientpower.europe
Glycosylation and stabilization of programmed death ligand 1 suppresses T cell...
 
01:08:12
Presented by: Chia-Wei Li, PhD - Instructor, Department of Molecular and Cellular Oncology, The University of Texas M. D. Anderson Cancer Center, USA Speaker Biography: I earned my Ph.D. degree in the Department of Pharmacology at the University of Medicine & Dentistry of New Jersey (UMDNJ) in 2007. Following graduation, I joined Dr. Mien-Chie Hung's lab at U.T. M.D. Anderson Cancer Center as a postdoctoral fellow. I was later appointed to an instructor position at MD Anderson. My research lies in understanding the regulatory mechanisms of PD-L1 for the identification of novel therapeutic targets, enhancing the efficacy and safety of immunotherapy. In addition, I have tremendous interest in studying breast cancer metastasis mechanisms, aiming to develop novel therapeutic strategies. Another focus of my research is on dissecting the PARP inhibitor resistance mechanism in triple negative breast cancer. I will use my research expertise in these areas as a Co-Investigator on Project 2 of the Breast SPORE. Webinar: Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity Webinar Abstract: The success of immune checkpoint blockade adds a new therapeutic category to the cancer therapy repertoire. Despite efforts made on cancer cell and immune cell interaction, how cancer cells initiate immune escape is less understood. Here we reveal PD-L1’s immunosuppression activity is stringently modulated by the spatial restraints between ubiquitination and N-linked glycosylation. We identified GSK3beta as a novel PD-L1 interacting protein capable of inducing phosphorylation dependent proteasome degradation. The essence of PD-L1 N192, N200 and N219 glycosylation suggests it antagonizes GSK3beta binding. In this regard, only non-glycosylated PD-L1 forms a complex with GSK3beta and beta-TrCP. More importantly, activation of GSK3beta-mediated PD-L1 degradation by TKI can reduce membrane PD-L1 expression and thereby enhance anti-tumor immunity. To test T cell-mediated cancer cell killing in vitro, we employed a time lapse microscopy, IncuCyte, to monitor RFP-tagged BT549 cells and activated PBMC interaction over a five day period. Massive cancer cell death was observed in glycosylation deficient cancer cells, suggesting glycosylation of PD-L1 is required for its immunosuppression. Together, our results link ubiquitination and glycosylation pathways with stringent regulation of PD-L1, proposing a new therapeutic strategy to enhance cancer immune therapy efficacy. Learning Objectives: -Molecular mechanism of PD-L1 regulation in cancer cells -Immunosuppressive nature of triple negative breast cancer -Using in vitro co-culture system to analyze T cell-mediated cancer cell killing effect Sponsored by: Essen BioScience Earn PACE Credits: 1. Make sure you’re a registered member of LabRoots (https://www.labroots.com/ms/webinar/glycosylation-stabilization-programmed-death-ligand-1-suppresses-t-cell-activity) 2. Watch the webinar on YouTube or on the LabRoots Website - https://www.labroots.com/ms/webinar/glycosylation-stabilization-programmed-death-ligand-1-suppresses-t-cell-activity 3. Click Here to get your PACE credits (Expiration date –September 07, 2019 09:00 AM) - http://www.labroots.com/credit/pace-credits/2398/third-party LabRoots on Social: Facebook: https://www.facebook.com/LabRootsInc Twitter: https://twitter.com/LabRoots LinkedIn: https://www.linkedin.com/company/labroots Instagram: https://www.instagram.com/labrootsinc Pinterest: https://www.pinterest.com/labroots/ SnapChat: labroots_inc
Views: 315 LabRoots
Breast cancer screening and prevention
 
04:30
VIDEO: Dr. Jennifer Crozier with Baptist MD Anderson Cancer Center talks about breast cancer screening and prevention.
Views: 10 WJXT - News4Jax
CAR T-cells - a new treatment option for ALL
 
01:26
Elias Jabbour, MD from University of Texas MD Anderson Cancer Center, Houston, USA gives a brief overview of CAR T-cells which are patient's own T-cells engineered in a laboratory to cure cancer. The T-cells are genetically engineered to produce special receptors on their surface called chimeric antigen receptors (CARs). These engineered CAR T-cells are then infused back into the patient. They multiply in the patient’s body and, with guidance from their engineered receptor, recognize and kill cancer cells that have the antigen on their surfaces. Recorded at the American Society of Hematology (ASH) 2015 Annual Meeting, at Orlando, FL. Visit our website | http://www.patientpower.eu/ Follow on Twitter | https://twitter.com/patientpowereu Like on Facebook | https://www.fb.com/patientpower.europe
How can ALL treatment be tailored for me?
 
00:58
Elias Jabbour, MD from University of Texas MD Anderson Cancer Center, Houston, USA explains how patient's individual cirstumstances affect treatment decisions. Age is an important factor for chemotherapy with older patients being at risk if high dose is used. Pros and cons need to be considered in order to maximise treatment outcome with cure being the ultimate goal for every patient. Recorded at the American Society of Hematology (ASH) 2015 Annual Meeting, at Orlando, FL. This programme has been supported by Pfizer, through an unrestricted educational grant to the Patient Empowerment Foundation Visit our website | http://www.patientpower.eu/ Follow on Twitter | https://twitter.com/patientpowereu Like on Facebook | https://www.fb.com/patientpower.europe
Cancer Radiation Parotid Gland MD Anderson Mask
 
03:54
Click Here http://www.IamFightingCancer.com Cancer Radiation Parotid Gland MD Anderson The tumor stable condition. A yr later it metastasized & got in my lung. 2 months ago it got in to my pericardium, the sack around my heart. with a liter of fluid I get a dose of herceptin (Trastuzumab) used for breast cancer every 3 wks. $10,000 a shot. Radiation killed the tumor. My left cheek is numb.Whiskers don't grow on the left side.. The Parotid gland gives you saliva necessary to eat. I used a feeding tube for 4 months. Saliva is back. There are multiple details in my pain journal http://www.IamFightingCancer.com. Everything here may not be of interest to you. I started in May of 2004 with the painful electrical shocks to the head which got worse and worse for about a year. The pain was know as the one of the most painful medical disorders called Trigeminal Neuralgia. This happens rarely in 1 of 25,000 people. A year later it was discovered that I had a parotid (Salivary) gland tumor too deep to operate on safely without significant disfigurement of the face. Your salivary glands very valuable. They give you saliva which you can not eat without. Initially I had 3 chemo treatments along with 33 radiation treatments. The electrical shock stopped after the first chemo. The Trigeminal Neuralgia portion is on the top half of medical website journal. The cancer portion of this journal is in the lower half of this letter. " I predict that by May 10, 2017 it will become standard in at least one state that any doctor that does not prescribe nutrition control in cancer treatment will be subject to being guilty of "Medical Malpractice". Click here :http://www.iamFightingCancer.com/Beating-Cancer-With-Nutrition/Patrick-Quillin.html to buy the best book on the planet about nutrition "Beating Cancer With Nutrition." by Patrick Quillin, PhD, Rd, CNS. The book comes with a handy CD. I have a compendium site about this book. Go to:http://www.iamFightingCancer.com/Beating-Cancer-With-Nutrition/Patrick-Quillin.html You can play the cd in the background of this website or while you read my website " www.IamFightingCancer.com to learn more about nutrition. Real Player -- 1.1 MB Click Here and Wait 30 Seconds. My bouts with parotid gland cancer and cancer in my left lung have been treated successfully by Chemotherapy, Radiation, Herceptin, aka trastuzumab, Zometa, Nutrition Improvement and of course Prayer. I think you can NOT afford to not be doing ALL of the above. Most doctors have little to no formal training to learn about nutrition. They make their money from either cutting you or giving you adrugs Side effects of herceptin are almost zero. Click on http://www.NelsonIdeas.com where I have 342 interesting & educational websites including topics on :   Pet Diarrhea, Constipation, Car Safety, Hybrid      Cars, Cancer Fighting Foods, Dogs Detecting   Cancer, Prostate/Head-Neck/Lung/Parotid Gland       Cancer, Treatment of Cancer by Radiation, Chemo, Nutrition & Prayer, Computer Information, Consulting, Inventions,      Entrepreneur Marketing, Web Page Critique    Defective Products, Trusses, Bridges, Tunnels       Dams, Farm Machinery, Pool Repair, China,     Humor, Funny Mini-Movies, Slide Shows, YouTube Videos, Changing Ideas, Surplus Merchandise, Party Tents, Clear Tarps, Global Warming, Mesh Cloth, Blinds  Drapes, Best Houston Restaurants, Medical Malpractice, Percussion Free Classified Ads, Ebay, Amazon,  Holidays, TMJ Aneurysms, Cooking, Heart Attack, Foreign Accent Syndrome, Poison Ivy, Liver Malfunction, Sleep Disorders, Presidential Candidates, Coughs, Blood Pressure, Fibromyalgia, Ear-ache Pain, Depression, Sneezing, Sciatica, Arthritis, Epilepsy, AdWords Prescriptions, Side  Effects, Weight Gain Money, AdSense, I Bonds, Reverse Mortgages Tax Lien Certificates, Wealth Creation Seminars,  Political Candidates, Food, Addiction to Oil, God, Prayer, SEO Conservation, Recycling, Real Estate, Bible Pronunciation, Bible Training, Marketing Jesus Christ, Religion Internet, The Pelamis Wave Power Machine, Video Cameras, Awnings, Canopies, Dome Tents, Backyard Movie Screens, Travel, Cruises, Bed & Breakfast  Clubs, Trigeminal Neuralgia, Shingles, Mold Dog Detection, Mining Collapse, Instinct, Video Ratings, Radio Wave Cancer Treatment, Salt Water Burning, Stupid Things, Duds, Christmas, Valentines Day, Video Directories, YouTube Information, Warranties and Guarantees, Eternal Life, Defective Products, Great Products, Erosion Control, Immigration, Futurism, Biometrics, MDLC, MDPC, Prescriptions, Tent History,Golf Shade Shelters, JB Nelson Family, Think Tanks, Neruovascular Intervention, Stimulators, Free Dirt, etc. My Website Directory is : http://www.NelsonIdeas.com YouTube Video User Name is BrianNelson123
Views: 13925 BrianNelson123
How should we treat immature B-cell ALL (Burkitt's disease)?
 
01:13
Elias Jabbour, MD from University of Texas MD Anderson Cancer Center, Houston, USA discusses treatment options for immature B-cell ALL, also known as Burkitt's disease. An intensive chemotherapy treatment starts quickly after diagnosis. This combined with new drugs (e.g. rituximab) greatly improves survival chances. Recorded at the American Society of Hematology (ASH) 2015 Annual Meeting, at Orlando, FL. This programme has been supported by Pfizer, through an unrestricted educational grant to the Patient Empowerment Foundation Visit our website | http://www.patientpower.eu/ Follow on Twitter | https://twitter.com/patientpowereu Like on Facebook | https://www.fb.com/patientpower.europe
How does chemotherapy work?
 
02:10
http://www.mdanderson.org/patient-and-cancer-information/cancer-information/cancer-topics/cancer-treatment/chemotherapy/index.html MD Anderson in Katy's Dr. Sunil Patel describes how different chemotherapies attack cancerous cells, and how physicians decide the frequency of chemotherapy treatments. Like us on Facebook https://www.facebook.com/MDAndersonKaty to learn more about what MD Anderson in Katy can offer you.
Curing Cancer | TechKnow
 
25:01
Curing Cancer: An innovative gene therapy has produced a significant breakthrough that could lead to a cure for cancer. In this episode of TechKnow, we look into the science of immunotherapy, which involves tricking the body's immune system into attacking cancerous tumours. Donated T-cells are given an extra gene to make them target specific leukaemia cells and other genes are disabled to prevent them from attacking their host. We also explore a promising cancer drug called Pembrolizumab. This drug makes the tumour visible to the T-cells. This new wave of cancer-fighting drugs, called immunotherapy, are the brainchild of Dr James Allison and his partner and wife, Dr Padmanee Sharma, who both work at MD Anderson Cancer Center in Houston, Texas. "Jim Allison's breakthrough changed the whole field. What he recognised is the immune system doesn't just have 'on' switches, it has 'off' switches. It's the yin and the yang of the immune system. If you keep trying to turn it on, it has its own internal controls to keep it turned off," explains Dr Sharma. "He recognised that if you want the T-cells to really attack cancer, you have to turn off the 'off' signal. So you have to block the brakes." The human immune system is built around white blood cells, which scientists call T-cells. When a T-cell senses an infection, it will attack. But with many cancers, T-cells will not attack because tumour cells are blocking their attacking mechanism. Dr Allison's and Dr Sharma's immune checkpoint therapy overrides those blocking systems, allowing the T-cells to do their job. David Wight, who has received treatment for bladder cancer at MD Anderson, is living proof that immunotherapy works. David is in remission, and his life has been extended beyond what anyone imagined. But according to Dr Sharma, immunotherapy is not for everyone. "Around 20 percent or so do very well … It gives us hope that we can build on this 20 percent to make it 50 percent, 80 percent, maybe 100 percent," she explains. Besides checkpoint inhibitor immunotherapy, adoptive cell transfer, known as ACT therapy, is also in the fight against cancer. With ACT, scientists in the Paris-based lab, Cellectis, are genetically manipulating T-cells and turning them into optimum cancer-killing machines. In 2015, Dr Andre Choulika's immunotherapy treatment was tested on its first human subject, Layla Richards, a one-year-old leukaemia patient. After receiving a single dose of genetically engineered T-cells, Layla went into complete remission within a few weeks. As of October 2016, Layla Richards remains in remission. A second young patient was also given the T-cell treatment and, while she has not been identified, she is reportedly also in remission. More from TechKnow on: Twitter - https://Twitter.com/AJTechKnow Website - http://aljazeera.com/TechKnow Subscribe to AJE on YouTube - http://aje.io/YTsubscribe - Subscribe to our channel: http://aje.io/AJSubscribe - Follow us on Twitter: https://twitter.com/AJEnglish - Find us on Facebook: https://www.facebook.com/aljazeera - Check our website: http://www.aljazeera.com/
Views: 17016 Al Jazeera English
Ronald DePinho, MD: Aging and Cancer: Can We Do One Without the Other?
 
14:52
Dr. Ronald DePinho discusses cancer and aging now and as we look to the future at the American Association for Cancer Research (AACR) Annual 2012 meeting in Chicago. Ronald DePinho, M.D., internationally recognized for basic and translational research in cancer, aging and age-associated degenerative disorders, is the fourth full-time president of The University of Texas MD Anderson Cancer Center. His appointment began on Sept. 1, 2011.
What is a fluoroscopy?
 
02:59
Fluoroscopy uses x-rays to create images of the internal organs in real time. Computers help create images of the structures while oral contrast is used to enhance these images. Fluoroscopy is used to help diagnosis problems with your esophagus, stomach, duodenum and small bowels. This procedure allows doctors to visualize the movement of oral contrast through the digestive system in real time. If you are scheduled for a fluoroscopy, don't eat or drink anything, other than water, after midnight. You should have had no other contrast studies within 24-48 hours of your exam. Bring a list of your current medicines. You may take your regular medicine with small amounts of water. Drink plenty of water the day before and after the exam. Tell the nurse or technologist if you are allergic to any medicine or have received a high density contrast procedure (example: barium swallow or CT scan). For more information on fluoroscopy and other diagnostic testing, visit our website http://www.mdanderson.org/patient-and-cancer-information/cancer-information/cancer-topics/detection-and-diagnosis/diagnostic-tests/di-procedures.html?_ga=1.118058185.110515486.1442323176
2010 National Patient | Survivor | Caregiver Conference
 
00:56
Join us for a full day of information and inspiration at the world-renown M. D. Anderson Cancer Center, in Houston, Texas, on Saturday, April 24. People are living longer with kidney cancer. Learn why. Hurry! Registration is filling fast. Click "Calendar of Events" on the home page at www.KidneyCancer.org to sign up today!
Views: 105 Kidney Cancer
Proton Therapy Treatment for Lymphoma
 
02:59
MD Anderson Proton Therapy Center physician Dr. Daniel Gomez discusses the circumstances in which proton therapy is appropriate for lymphoma treatment, the benefits of proton therapy for lymphoma and what makes lymphoma patients unique. If you would like to learn more about proton therapy treatment for lymphoma please visit our website at http://mdanderson.org/proton
Doctors Brave Harvey Floods To Save Cancer Patient’s Life | TODAY
 
03:09
Roads became impassable when Hurricane Harvey slammed ashore on Saturday, but a group of doctors in the region stopped at nothing to make sure one of their patients at MD Anderson Cancer Center got his life-saving treatment. NBC medical correspondent Dr. John Torres reports for TODAY. » Subscribe to TODAY: http://on.today.com/SubscribeToTODAY » Watch the latest from TODAY: http://bit.ly/LatestTODAY About: TODAY brings you the latest headlines and expert tips on money, health and parenting. We wake up every morning to give you and your family all you need to start your day. If it matters to you, it matters to us. We are in the people business. Subscribe to our channel for exclusive TODAY archival footage & our original web series. Connect with TODAY Online! Visit TODAY's Website: http://on.today.com/ReadTODAY Find TODAY on Facebook: http://on.today.com/LikeTODAY Follow TODAY on Twitter: http://on.today.com/FollowTODAY Follow TODAY on Google+: http://on.today.com/PlusTODAY Follow TODAY on Instagram: http://on.today.com/InstaTODAY Follow TODAY on Pinterest: http://on.today.com/PinTODAY Doctors Brave Harvey Floods To Save Cancer Patient’s Life | TODAY
Views: 3237 TODAY
Dr. James Cox Discusses New Phase II Lung Cancer Study at the Proton Therapy Center
 
06:37
Dr. Cox explains the outcomes of proton therapy with concurrent chemotherapy, how lung cancer patients typically tolerate treatment and what the future holds for lung cancer patients being treated with proton therapy at MD Anderson. For more information on MD Anderson's Proton Therapy Center you can visit the website at http://mdanderson.org/proton
How prostate cancer changed me
 
01:09
After undergoing prostate cancer treatment at The University of Texas MD Anderson Cancer Center, Robert Wright became involved in prostate cancer support groups as a way to give back and help others. This is just one of the ways that prostate cancer changed Robert. Watch this video to learn more. Learn about MD Anderson’s Prostate Cancer Moon Shot: http://www.cancermoonshots.org/cancer-types/prostate/ Schedule an appointment at MD Anderson: https://www4.mdanderson.org/contact/selfreferral/index.cfm #endcancer.
New treatments: it's important to ask questions
 
03:07
At the American Society of Hematology (ASH) 2015 Annual Meeting held in Orlando FL., Dr Naval Daver from the University of Texas MD Anderson Cancer Center, Houston, TX, provides advice on how to approach your doctor with questions regarding your treatment and the options available to you. Dr Daver gives a few examples of the importance of raising these questions, and how to do it in an efficient manner. This programme has been supported by Pfizer, through an unrestricted educational grant to the Patient Empowerment Foundation. Visit our website | http://www.patientpower.eu/ Follow on Twitter | https://twitter.com/patientpowereu Like on Facebook | https://www.fb.com/patientpower.europe
The Role of Bisphosphonates in Breast Cancer Treatment
 
03:42
Much-anticipated and highly-disappointing results were presented at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium. In an international trial of 3,360 women, the bone-building drug Zometa, failed to prevent breast cancer recurrence and found no disease-free survival benefit among the majority of women with Stage II/III disease. Bisphosphonates role in the treatment of breast cancer has been an active area of research focus, as previous clinical trials had shown that the class of drugs may have anti-cancer activity. Sharon Giordano, M.D., associate professor in MD Anderson's Department of Breast Medical Oncology, was a commentator on the press program shares her perspective
Progress in treatment options for precursor B-cell ALL
 
00:47
Elias Jabbour, MD from University of Texas MD Anderson Cancer Center, Houston, USA discusses a study for precursor B-cell ALL presented at ASH 2015 where a combination of chemotherapy with rituximab showed promise for long-term outcomes. Recorded at the American Society of Hematology (ASH) 2015 Annual Meeting, at Orlando, FL. Visit our website | http://www.patientpower.eu/ Follow on Twitter | https://twitter.com/patientpowereu Like on Facebook | https://www.fb.com/patientpower.europe
[Webinar] Optimizing Nutrition | Pancreatic Cancer Action Network
 
01:17:16
This webinar discusses common nutritional challenges associated with pancreatic cancer, treatment and surgery including tips for eating and getting the best results from pancreatic enzymes. Thank you to our webinar sponsor – Ipsen. PRESENTERS: Jeannine Mills, MS, RD, CSO, LD – Dartmouth Hitchcock Medical Center Maria Petzel, RD, CSO, LD, CNSC, FAND – The University of Texas MD Anderson Cancer Center RECORDED: Mar 19, 2018 ################ Do you know someone diagnosed with pancreatic cancer? Direct them to Patient Central for information, resources and hope. Call 877-2-PANCAN, email patientcentral@pancan.org or visit http://pcan.at/pty. Associates are available Monday – Friday, 7 a.m. – 5 p.m. PT. ################ CONNECT WITH US WEBSITE: http://pcan.at/PC FACEBOOK: http://facebook.com/JoinTheFight TWITTER: http://twitter.com/pancan INSTAGRAM: http://instagram.com/pancan YOUTUBE: https://youtube.com/StopPancreaticCancer and MORE: http://pancan.org/social-media ################ ABOUT PANCREATIC CANCER ACTION NETWORK The Pancreatic Cancer Action Network (PanCAN) is dedicated to fighting the world’s toughest cancer. In our urgent mission to save lives, we attack pancreatic cancer on all fronts: research, clinical initiatives, patient services and advocacy. Our effort is amplified by a nationwide network of grassroots support. We are determined to improve patient outcomes today and to double survival by 2020.
[Webinar] Pancreatic Neuroendocrine Tumor (PNET) | Pancreatic Cancer Action Network
 
59:29
This webinar discusses treatment approaches and highlights research developments for pancreatic neuroendocrine tumors (PNETs). PRESENTER: Daniel M. Halperin, MD – The University of Texas MD Anderson Cancer Center RECORDED: Dec. 12, 2017 ################ Do you know someone diagnosed with pancreatic cancer? Direct them to Patient Central for information, resources and hope. Call 877-2-PANCAN, email patientcentral@pancan.org or visit http://pcan.at/pty. Associates are available Monday – Friday, 7 a.m. – 5 p.m. PT. ################ CONNECT WITH US WEBSITE: http://pcan.at/PC FACEBOOK: http://facebook.com/JoinTheFight TWITTER: http://twitter.com/pancan INSTAGRAM: http://instagram.com/pancan YOUTUBE: https://youtube.com/StopPancreaticCancer and MORE: http://pancan.org/social-media ################ ABOUT PANCREATIC CANCER ACTION NETWORK The Pancreatic Cancer Action Network (PanCAN) is dedicated to fighting the world’s toughest cancer. In our urgent mission to save lives, we attack pancreatic cancer on all fronts: research, clinical initiatives, patient services and advocacy. Our effort is amplified by a nationwide network of grassroots support. We are determined to improve patient outcomes today and to double survival by 2020.
Space Suit Art Project brings hope to pediatric cancer patients
 
03:13
Two of Space City’s best-known institutions — The University of Texas MD Anderson Cancer Center and the National Aeronautics and Space Administration (NASA) — have partnered to bring the benefits of arts and science to pediatric cancer patients while increasing awareness of childhood cancer. More than 531 patients, families, and staff members painted original artwork used to create full-sized space suits for the Space Suit Art Project. Born out of an idea from MD Anderson’s Arts in Medicine Program, which helps pediatric patients cope with cancer treatment through art, this project inspired leaders at NASA’s International Space Station (ISS) to support the effort with help from astronauts, scientists and engineers. NASA provided patterns for the suits and worked with ILC Dover, a manufacturing and engineering company that develops NASA space suits. ILC Dover assembled the suits by stitching the hand-painted art pieces onto the fabric.
Institute for Applied Cancer Science
 
02:34
http://bit.ly/GIXIL5 MD Anderson Cancer Center's Institute for Applied Cancer Science focuses on accelerating the delivery of new, safe and highly-effective therapeutics for cancer patients. It brings together renowned scientists from around the world and MD Anderson's 18,000-strong "strike-force" against cancer. Blending the best attributes of academic and industrial research, it will identify and validate new cancer targets, convert that scientific knowledge into new drugs and advance them into clinical trials. The scientists share expertise in: Cancer biology, cancer genomics, clinical trials, computational science and bioinformatics, drug discovery, genetics and pharmacology. It's a unique organization, integrating genomic information, deep-target biology and drug discovery within one team. Its single vision -- to radically improve survival rates for people who suffer from several major cancers within the next 10 years -- is a major assault in the fight against cancer. The Insitute for Applied Cancer Science is recruiting world-class scientists. Apply online via our website. http://bit.ly/GIXIL5
Cancer prevention: what is energy balance?
 
16:51
Download this podcast from iTunes: https://itunes.apple.com/us/itunes-u/cancer-prevention-what-is/id431848216?i=133226167. What is energy balance? It may sound like a strange term, but it basically means equalizing the amount of calories you take in with how much you burn through exercise, metabolism and body processes. Since obesity is one of the leading causes of cancer, Carrie Daniel-MacDougall, Ph.D., M.P.H. and Susan Schembre, Ph.D., R.D., both assistant professors in Cancer Prevention and Population Sciences at MD Anderson Cancer Center, study behaviors and biological processes associated with linking energy balance to cancer risk and survival. Listen to Daniel-MacDougall and Schembre share advice on how you can get the proper balance between eating and exercise to stay healthy.
American Brain Tumor Association Webinar: Coping with Depression, Anxiety and a Brain Tumor
 
56:46
A person diagnosed with a brain tumor can be at high risk for depression and/or anxiety. These emotional conditions can be successfully treated if they are identified as early as possible. Sign up for this interactive webinar, presented by Mary K. Hughes, CNS, RN from the Department of Psychiatry at the University of Texas M.D. Anderson Cancer Center. This session highlights the signs and symptoms of depression and anxiety and how they can affect the quality of life of someone living with a brain tumor. The importance of early detection and treatment of depression and/or anxiety will be a focus of the webinar. View additional educational videos anytime anywhere at: http://www.abta.org/brain-tumor-information/anytime-learning/ Learn about upcoming webinars and register for free at: http://www.abta.org/brain-tumor-information/webinars.html
Pediatric Cancer Survivor Gage Hancock-Stevens Sings
 
04:26
12-year-old childhood cancer patient Gage Hancock-Stevens sings two of his favorite songs, "Lean on Me" and "When I Close My Eyes" at Houston's Ronald McDonald House. The MD Anderson Proton Therapy Center team also had the chance to chat with Gage about his passion for music, love of animals, and his thoughtful advice for other kids going through proton therapy treatment. Though Gage has been blind since he was 2 years old, that hasn't stopped him from following his dreams. For more information on MD Anderson's Proton Therapy Center you can visit the website at http://mdanderson.org/proton
Strategies to help you improve treatment tolerance and outcome
 
03:31
At the American Society of Hematology (ASH) 2015 Annual Meeting held in Orlando FL., Dr Naval Daver from the University of Texas MD Anderson Cancer Center, Houston, TX, provides guidance to patients that want to contribute to the management of their disease. Dr Daver covers topics such as the use of alternative medicines, diet and exercise. This programme has been supported by Pfizer, through an unrestricted educational grant to the Patient Empowerment Foundation Visit our website | http://www.patientpower.eu/ Follow on Twitter | https://twitter.com/patientpowereu Like on Facebook | https://www.fb.com/patientpower.europe
Cancer Survivor Story - Denille - Stage 4 Triple Negative Breast Cancer
 
08:47
If you want to learn how Denille beat breast cancer, watch this video now. Her doctors gave her a death sentence… so how is she 100% cancer free today? She was a healthy young woman with two children… until she found a lump in her breast. See how Denille struggled as things went from bad to worse - stage 2 to a devastating stage 4 diagnosis. Why she gave up on conventional treatments. And the amazing story of her message from God about what to do. Next you’ll discover which holistic health doctor for breast cancer healed Denille’s cancer. Her remarkable results in only 2 weeks of all natural breast cancer treatment! And she tells the stories of healing miracles she witnessed in other patients with cancer. Find out about alternative breast cancer treatments that worked for Denille and others. They may work for you and your loved ones who are currently fighting cancer, too. If you like this video, please give it a thumbs up and share it with others you love and care about. WATCH MORE INCREDIBLE CANCER SURVIVOR STORIES: http://bit.ly/cancer-survivor-story-yt ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ Have you survived a cancer diagnosis and lived to tell about it? We hear so many amazing stories from our readers about how they beat cancer using the very techniques they’ve learned from The Truth About Cancer… and we’d love to hear YOUR story! Sharing these stories brings hope to those who have been diagnosed with or are currently dealing with cancer. So, if you have a personal story to share of your triumph over cancer, please follow this link and tell us all about it: http://bit.ly/your-cancer-survivor-story-yt . Each week we’ll post a new story on our site from the submissions. ----------------------------------------------------------------------------------------------------------- Visit our website: http://bit.ly/official-website-ttac-yt Join TTAC's 1 million FB fans: http://bit.ly/TTAC-Facebook-YT Follow us on PINTEREST: http://bit.ly/TTAC-Pinterest-YT Find us on INSTAGRAM: http://bit.ly/TTAC-Instagram-YT Support our mission by commenting and sharing with your friends and family below. -------------------------------------------------- About The Truth About Cancer -------------------------------------------------- The Truth About Cancer’s mission is to inform, educate, and eradicate the pandemic of cancer in our modern world. Every single day, tens of thousands of people just like you are curing cancer (and/or preventing it) from destroying their bodies. It’s time to take matters into your own hands and educate yourself on real cancer prevention and treatments. It could save your life or the life of someone you love. --------------------------------------- About Ty Bollinger --------------------------------------- Ty Bollinger is a devoted husband, father, a best-selling author, and a Christian. He is also a licensed CPA, health freedom advocate, cancer researcher, former competitive bodybuilder, and author of the best-selling book Cancer - Step Outside the Box, which has sold over 100,000 copies worldwide. After losing his mother and father and several family members to cancer, Ty’s heartbreak and grief coupled with his firm belief that chemotherapy, radiation, and surgery were the NOT the most effective treatments available for cancer patients led him on a path of discovery. He began a quest to learn everything he possibly could about alternative cancer treatments and the medical industry. What he uncovered was shocking. On his journey, he’s interviewed cutting-edge scientists, leading alternative doctors, and groundbreaking researchers to learn about hidden alternative cancer treatments. What he uncovered help to create The Truth About Cancer and its 3 awe-inspiring docu-series: The Quest for The Cures, The Quest For The Cures Continues, and The Truth About Cancer: A Global Quest. Ty has touched the hearts and changed the lives of thousands of people around the world. Ty speaks frequently at conferences, local health group meetings, churches, and guest stars on multiple radio and TV shows and writes for numerous magazines and websites. ----------------------------------------------------------------------------------------------------------- The Truth About Cancer,truth about cancer,the truth about cancer event,ty bollinger,global quest,a global quest,breast cancer survivor story,cancer survivor stories,how to cure cancer naturally,healing cancer naturally,Alternative cancer treatments,cancer survivor story
Learn Inflammatory Breast Cancer (IBC)  from the Expert Part III
 
12:24
This is a radio interview of Naoto T Ueno, MD, PhD by Terry Arnold. This is a three part series of Part III. Dr. Ueno is the Executive Director of the Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, Section Chief, Section of the Translational Breast Cancer Research, Department of Breast Medical Oncology at The University of Texas MD Anderson Cancer Center, Houston, Texas. Ms. Terry Arnold was working for a radio station. She is also an inflammatory breast cancer survivor. Web: Page: http://www.mdanderson.org/IBCProgram Facebook Page: http://www.facebook.com/NoMoreCancer http://www.facebook.com/InflammatoryBreastCancer http://www.facebook.com/ntueno Twitter Page: http://twitter.com/InflammatoryBCa http://twitter.com/teamoncology
Views: 519 Naoto Ueno
My Cancer Risk:  What Do I Need to Know?
 
02:19
My Cancer Risk: What Do I Need to Know? More info: http://bit.ly/zVSRcY Certain risk factors, including genetics, may raise your cancer risk. Therese Bevers, M.D., medical director of the Cancer Prevention Center at MD Anderson, discusses factors that may put you at increased risk for cancer. Video transcript: First off, your own personal health history; there are some medical conditions that can increase your risk of developing cancer. For example, inflammatory bowel disease increases the risk of colon cancer. Having a history of colon polyps that are precancerous increases your risk of colon cancer. If you have an HPV infection, human papillomavirus, that can increase your risk for a number of cancers: cervical, and oral, and anal, and penile. So, knowing these risks help us to identify who is at increase risk and may need additional or more frequent screening. Additionally, a cancer survivor is at increase risk of a second primary cancer. In other words, a totally new cancer, generally unrelated to the first although in some cases it may be related to a common genetic link or even to the treatment that we offered for the original cancer. Certainly, having a family history of cancer puts an individual at increase risk especially if they have identified mutation in cancer causing genes and there are several of those genes that have been identified such as for breast cancer. Many of us have heard about B-R-C-A or BRCA. There's also genes for colon cancer and others. Racial and ethnic background can increase your risk. I think probably a lot of the men in the room are familiar that African-American men are at higher risk of developing prostate cancer. Hispanic women are at higher risk of cervical cancer. Ashkenazi Jewish women are at higher risk of breast cancers. So, these are all factors that we want to consider in understanding what an individual's cancer risk is. We have developed a cancer risk check and it's on the MD Anderson website. If you go to mdanderson.org/riskcheck, you can go in and answer a series of questions and it will help you to understand what your cancer risk is and what cancer screening test we would recommend based on that individual level of cancer risk. Video description: Therese Bevers, M.D., professor in the Department Clinical Cancer Prevention and medical director of the Cancer Prevention Center at MD Anderson discusses risk factors for cancer at the 2011 Prostate Health Conference, "Protect Your Prostate: Get the Facts," September 10, 2011, Houston, Texas. John W. Davis, M.D., assistant professor in the Department of Urology at MD Anderson, chairs this educational conference for healthy men and those with prostate cancer, as well as their families. The Prostate Health Conference updates men on current issues in prostate health, prostate cancer, cancer risk factors, treatment, research, education and prevention. MD Anderson has specific screening plans for men and women, based on their chances of getting cancer. The exam you get and how often you are tested depends on whether you are at average, increased or high risk for cancer. People at increased risk have a higher chance of getting the disease than those at average risk. It's important to know if people in your family have had cancer and, if so, what type. This information, along with your personal health history, helps your health care provider find out if you're at increased or high risk. You and your doctor can use this information to make a well-informed decision about cancer screening. View the complete 2011 Prostate Health Conference: http://bit.ly/y10drf
MD Anderson Cancer Center Houston Main Building - Controlled Demolition, Inc. - YouTube.flv
 
06:29
Footage of the implosion of the MD Anderson Cancer Center Houston Main Building in Houston, Texas on January 8, 2012. Sigma provided engineering calculations and field support to our partner Controlled Demolition Inc. (CDI). This footage is provided as a courtesy by CDI. Please visit CDI's website (www.controlled-demolition.com) and their YouTube Channel(http://www.youtube.com/user/TheLoizeauxGroupLLC?feature=g-all-u).
Views: 529 SigmaNV
GoodTaste.tv - Wine Night For One INCREDIBLE Cause...Be a Part of History!
 
05:01
Goodtaste.tv There's a big breakthrough in cancer research — we may be on the verge of a cure for prostate cancer! It's a topic that is very close to the hearts of father and son restaurant owners Tony and Russell Masraff. And guess what? The ground-breaking developments began right here in Uptown, at Masraff's on the Boulevard. With "nothing to treat and everything to cure," this dynamic duo has spearheaded this cause ever since Tony himself was diagnosed with the disease over a decade ago. Shortly after, in 2002, he founded Tony's Prostate Cancer Research (TPCR), his non-profit that spends 100% of every dollar donated or raised to fund more research for a cure. And now — we're so close! I met with Dr. Timothy Thompson at the MD Anderson Cancer Center in Houston, and he said he's never seen anything this promising. While prostate cancer is known to be handed down from generation to generation, these scientists have managed to isolate a protein we all produce and use it to cure prostate cancer in rats. Essentially this "GLIPR1″ protein is finding the cancer cells in the rats, bind to the proteins that cause the cancer and eliminate the cells! Just incredible... Tony Masraff's first fundraiser to find a cure was the Chevron Houston Marathon, where by the time he was ready to start, he already had over $140,000 dollars in pledges from customers, friends and family. Never being a 'running type' as Tony jokes, he was unsure of himself at first. And, in dramatic fashion, collapsed near the finish line and actually crawled his way to completion...WOW! Needless to say, his triumphant finish set the stage for further research, and today he and Russell, as well as all of their staff, continue to work around the clock to raise money for the next phase: FDA human trials. Most of this money comes from private donation, however the family also hosts two major fundraisers per year: their annual Redstone golf tournament each spring, and on September 28 an AMAZING Evening of Hope -- Wine Extravaganza that features tastings of many high-end wines from around the globe...wines like Ornellaia and Darius II for starters! Their goal is to raise 1.5 million dollars to pay for the human trials — and every single penny you donate goes straight to this goal. Let's be a part of history shall we! More information can be found on Tony's foundation website at: tpcr.org. Tony is also a prostate patient advocate at MD Anderson, and has made himself personally available to anyone who calls. His cell phone number is included at the end of our video, and can also be found on the website listed above.
Dr. John P Williams: Breast Cancer Surgeon & Advocate
 
01:56
Dr. John P. Williams is a national leader in patient education and advocacy. A breast cancer surgeon in Northern Virginia, he founded the Breast Cancer School for Patients. VISIT THE BREAST CANCER SCHOOL FOR PATIENTS: http://www.breastcancercourse.org LIST OF QUESTIONS FOR YOUR DOCTORS: http://www.breastcancercourse.org/breast-health-updates-latest-videos/ FOLLOW US: Facebook: https://www.facebook.com/Breast-Cancer-School-for-Patients-958519147618444/ _______________________________________ Why create the Breast Cancer School for Patients? Over the years, family and friends have called me for advice about their breast care. After a quick conversation, they were incredibly empowered to ask their own doctors exactly what was needed. You simply get better care when you know about the important topics and the questions to ask. That is why we created the Breast Cancer School for Patients. Currently, the medical profession does not actually “teach” patients how to obtain quality, cutting-edge care in their communities. This is a missing link in our collective efforts to provide better quality breast cancer care in the United States. We feel it should be our duty in healthcare to teach you what you need to know before you consult with your breast cancer physicians. This way you can be more engaged with your physicians about the complexities of cancer care. This information must be readily available online, well organized, and in short video format. Our sole mission at the Breast Cancer School for Patients is to fill this patient information gap online. You will make better treatment decisions when you are taught to be an “expert” in your own breast cancer care. What is a “team approach” to breast cancer? A large part of my general surgery training at Baylor College of Medicine in Houston, Texas was working with the experts in cancer treatment at the M. D. Anderson Cancer Center (MDACC). Also located in the Texas Medical Center, MDACC is the largest dedicated cancer hospital in the United States. My general surgery rotations there exposed me to the “team approach” to breast cancer. The cutting-edge care a multidisciplinary team can offer patients is why I founded the Novant Health UVA Health Systerm Breast Center in my community in Haymarket, Virginia. It is personally rewarding that those with breast cancer in my community will now benefit from this team approach for generations to come. Do you come from a family of physicians? Growing up, I knew that I would likely become a doctor. My grandfather, L. Polk Williams, Sr. MD, brought modern medicine to the small town of Edenton, North Carolina in the early 1920s. During the Great Depression, grateful patients would leave chickens and livestock at his back door in exchange for the house calls and lifesaving care he provided. My father, L. Polk Williams, Jr. MD, followed his father into medicine, also attending Wake Forest University and Bowman Gray School of Medicine. He returned to his home town of Edenton after training in general surgery at Baylor College of Medicine and brought Dr. Michael Debakey’s world-class surgical care with him. I was born in Edenton and grew up in Elizabeth City, just a short drive from there. Why is being a breast cancer surgeon rewarding? I find I am interconnected in so many ways to my patients. They call me with questions. I talk with them at the grocery store. I love being there as a physician and friend when they are in need. These personal relationships are the ultimate reward for being a dedicated physician. What drives me today is doing everything in my power to obtain the best care possible for my own patients. I use every ounce of thought and energy teaching them and guiding them to get the best possible breast cancer care. Where did you attend school and train to be a surgeon? I entered Duke University as a freshman knowing that becoming a doctor was my goal. I became fascinated by the complexities of the brain and soon found myself engaged in neurology research at Duke University School of Medicine while an undergraduate. I graduated with distinction in psychology, and then attended the University of North Carolina School of Medicine. Like my father, I trained in general surgery at Baylor College of Medicine with Dr. Debakey. He was the world’s greatest cardiovascular surgeon of the 20th century and a leader in promoting advances in medicine and in health. Professionally, I am most proud to have applied to breast cancer care the same pursuit of excellence that I learned from Dr. Debakey and his associates at Baylor in Houston, Texas. More about Dr. John P. Williams Dr. Williams is a breast cancer surgeon in Virginia. He founded and is medical director the Novant Health UVA Health System Breast Center which serves the communities of Manassas, Gainesville and Haymarket, Virginia. More information can be found at htttp://www.drjohnwilliams.com. .
Helen Piwnica-Worms (U. Texas) 2: Translating Cell Cycle Principles to Targeted Cancer Therapies
 
29:28
Helen Piwnica-Worms provides a historical perspective on cell cycle regulation and outlines important experiments that revealed crucial mediators of the cell cycle. Part 1: Frogs, Clams, Yeast & Human Cancer: Historical Perspective on Cell Cycle Regulation: Helen Piwnica-Worms provides a historical perspective on cell cycle regulation and outlines important experiments that revealed crucial mediators of the cell cycle. Part 2: Translating Fundamental Cell Cycle Principles to Targeted Cancer Therapies: Helen Piwnica-Worms explains how scientists have used their understanding of the cell cycle regulation to generate targeted cancer therapies. https://www.ibiology.org/ibioseminars/translating-fundamental-cell-cycle-principles-targeted-cancer-therapies.html Talk Overview: In her first talk, Dr. Helen Piwnica-Worms provides a historical perspective on cell cycle regulation and outlines important experiments in frogs, clams, and yeast that revealed crucial mediators of the cell cycle. Scientists observed that there were factors that allowed cell cycle progression, while there were other factors that prevented the cell from going backward. Using these model organisms, scientists were able to characterize the activation of the inducer of mitosis, the M-Phase promoting factor, which is a heterodimer between cyclin-dependent kinase (Cdc2/Cdk1) and cyclin B.    In her second talk, Piwnica-Worms explains how scientists have used their understanding of the cell cycle regulation to generate targeted cancer therapies. The cell has proteins that serve as cell cycle checkpoints, which allows the cell to respond appropriately to DNA damage. Although not all of the checkpoints are functional in a cancer cell, these cells still need the checkpoint proteins to respond to DNA damage. Piwnica-Worms’ laboratory studies the use of combining DNA damage agents with checkpoint inhibitors to selectively kill cancer cells. Her laboratory developed a patient-derived xenograft mouse model to study Triple Negative Breast Cancer (TNBC), and predict how the genotype of the tumor affects treatment. Speaker Biography: Dr. Helen Piwnica-Worms is professor of experimental radiation oncology at the University of Texas MD Anderson Cancer Center. She completed her bachelor’s degree in Biology at St. Olaf College in 1979, a doctoral degree in microbiology and immunology at Duke University Medical School in 1984, and a postdoctoral fellowship in pathology at the Dana-Farber Cancer Institute in 1988. In 1989, Piwnica-Worms joined the faculty of Tufts University Medical School, and in 1992 she moved to the Microbiology and Molecular Genetics department at Harvard Medical School. In 1994, she joined the faculty at Washington University School of Medicine in St. Louis, where she was the chair of Cell Biology and Physiology. Since 2013, Piwnica-Worms assumed the role of Vice Provost of Science and Professor of Experimental Radiation Oncology at the University of Texas MD Anderson Cancer Center. As a basic research scientist, she was interested in understanding how the cell cycle was regulated. She showed how basic research discoveries allow for a better understanding of molecular underpinnings that opens new strategies to treat diseases, like cancer. Using immunocompromised mice, her laboratory developed a mouse model to perform preclinical studies using breast cancer cells from patients. For her scientific contributions, she was an Investigator of the Howard Hughes Medical Institute from 1994 to 2011 and was elected as a member of the National Academy of Medicine in 2013. Learn more about Piwnica-Worms’ research at her lab website: https://www.mdanderson.org/research/departments-labs-institutes/labs/helen-piwnica-worms-laboratory.html
Views: 958 iBiology
Helen Piwnica-Worms (U. Texas) 1: A Historical Perspective on Cell Cycle Regulation
 
29:08
Helen Piwnica-Worms provides a historical perspective on cell cycle regulation and outlines important experiments that revealed crucial mediators of the cell cycle. Part 1: Frogs, Clams, Yeast & Human Cancer: Historical Perspective on Cell Cycle Regulation: Helen Piwnica-Worms provides a historical perspective on cell cycle regulation and outlines important experiments that revealed crucial mediators of the cell cycle. Part 2: Translating Fundamental Cell Cycle Principles to Targeted Cancer Therapies: Helen Piwnica-Worms explains how scientists have used their understanding of the cell cycle regulation to generate targeted cancer therapies. https://www.ibiology.org/ibioseminars/frogs-clams-yeast-human-cancer-historical-perspective-cell-cycle-regulation.html Talk Overview: In her first talk, Dr. Helen Piwnica-Worms provides a historical perspective on cell cycle regulation and outlines important experiments in frogs, clams, and yeast that revealed crucial mediators of the cell cycle. Scientists observed that there were factors that allowed cell cycle progression, while there were other factors that prevented the cell from going backward. Using these model organisms, scientists were able to characterize the activation of the inducer of mitosis, the M-Phase promoting factor, which is a heterodimer between cyclin-dependent kinase (Cdc2/Cdk1) and cyclin B.    In her second talk, Piwnica-Worms explains how scientists have used their understanding of the cell cycle regulation to generate targeted cancer therapies. The cell has proteins that serve as cell cycle checkpoints, which allows the cell to respond appropriately to DNA damage. Although not all of the checkpoints are functional in a cancer cell, these cells still need the checkpoint proteins to respond to DNA damage. Piwnica-Worms’ laboratory studies the use of combining DNA damage agents with checkpoint inhibitors to selectively kill cancer cells. Her laboratory developed a patient-derived xenograft mouse model to study Triple Negative Breast Cancer (TNBC), and predict how the genotype of the tumor affects treatment. Speaker Biography: Dr. Helen Piwnica-Worms is professor of experimental radiation oncology at the University of Texas MD Anderson Cancer Center. She completed her bachelor’s degree in Biology at St. Olaf College in 1979, a doctoral degree in microbiology and immunology at Duke University Medical School in 1984, and a postdoctoral fellowship in pathology at the Dana-Farber Cancer Institute in 1988. In 1989, Piwnica-Worms joined the faculty of Tufts University Medical School, and in 1992 she moved to the Microbiology and Molecular Genetics department at Harvard Medical School. In 1994, she joined the faculty at Washington University School of Medicine in St. Louis, where she was the chair of Cell Biology and Physiology. Since 2013, Piwnica-Worms assumed the role of Vice Provost of Science and Professor of Experimental Radiation Oncology at the University of Texas MD Anderson Cancer Center. As a basic research scientist, she was interested in understanding how the cell cycle was regulated. She showed how basic research discoveries allow for a better understanding of molecular underpinnings that opens new strategies to treat diseases, like cancer. Using immunocompromised mice, her laboratory developed a mouse model to perform preclinical studies using breast cancer cells from patients. For her scientific contributions, she was an Investigator of the Howard Hughes Medical Institute from 1994 to 2011 and was elected as a member of the National Academy of Medicine in 2013. Learn more about Piwnica-Worms’ research at her lab website: https://www.mdanderson.org/research/departments-labs-institutes/labs/helen-piwnica-worms-laboratory.html
Views: 2866 iBiology
Some groups of T-cell ALL patients need special attention
 
01:10
Elias Jabbour, MD from University of Texas MD Anderson Cancer Center, Houston, USA presents subgroups of T-Cell ALL, which need special attention to ensure a good treatment outcome. Early T-cell precursor ALL patients should be referred for transplantation. Elderly should avoid intensive chemotherapy, being treated with a lower dose chemotherapy and innovative agents. Blinatumomab could be used in patients with minimal disease. Recorded at the American Society of Hematology (ASH) 2015 Annual Meeting, at Orlando, FL. This programme has been supported by Pfizer, through an unrestricted educational grant to the Patient Empowerment Foundation Visit our website | http://www.patientpower.eu/ Follow on Twitter | https://twitter.com/patientpowereu Like on Facebook | https://www.fb.com/patientpower.europe
Learn Inflammatory Breast Cancer (IBC)  from the Expert Part I
 
13:39
This is a radio interview of Naoto T Ueno, MD, PhD by Terry Arnold. This is a three part series of Part I. Watch Part II after Part I. Dr. Ueno is the Executive Director of the Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, Section Chief, Section of the Translational Breast Cancer Research, Department of Breast Medical Oncology at The University of Texas MD Anderson Cancer Center, Houston, Texas. Ms. Terry Arnold was working for a radio station. She is also an inflammatory breast cancer survivor. Web: Page: http://www.mdanderson.org/IBCProgram FaceBook Page: http://www.facebook.com/NoMoreCancer http://www.facebook.com/InflammatoryBreastCancer http://www.facebook.com/ntueno Twitter Page: http://twitter.com/InflammatoryBCa http://twitter.com/teamoncology
Views: 2410 Naoto Ueno
Debbie Schmitz, RN, BSN Explains EJGH’s Cancer Care
 
00:15
Debbie Schmitz explains how East Jefferson General Hospital is known for its cancer care. EJGH is our region’s only member of the MD Anderson Cancer Network. Our physicians are the best of the best, with many years of experience providing excellent cancer care in Metairie. Visit us today at 4200 Houma Blvd, Metairie, LA 70006 or give us a call at (504) 454-4000. For more information, visit our website: http://www.ejgh.org/
Meet Pediatric Oncologist Clarke Anderson, M.D. | City of Hope
 
01:26
A pediatric oncologist at City of Hope, Dr. Clarke Anderson discusses the differences and similarities between adult and pediatric oncology. ################ CONNECT WITH US WEBSITE: http://www.cityofhope.org FACEBOOK: http://www.facebook.com/cityofhope TWITTER: http://www.twitter.com/cityofhope YOUTUBE: http://www.youtube.com/cityofhopeonline FLICKR: http://www.flickr.com/cityofhope BLOG: http://breakthroughs.cityofhope.org and MORE: http://www.cityofhope.org/getsocial ################ ABOUT CITY OF HOPE City of Hope is a leading research and treatment center for cancer, diabetes and other life-threatening diseases. Designated as a comprehensive cancer center, the highest recognition bestowed by the National Cancer Institute, City of Hope is also a founding member of the National Comprehensive Cancer Network, with research and treatment protocols that advance care throughout the nation. City of Hope's main hospital is located in Duarte, Calif., just northeast of Los Angeles, with clinics throughout southern California. It is ranked as one of "America's Best Hospitals" in cancer by U.S. News & World Report. Founded in 1913, City of Hope is a pioneer in the fields of bone marrow transplantation and genetics. For more information, visit http://www.cityofhope.org.
Views: 356 City of Hope
Circulating Tumor Cells Clinical Utility, Challenges and Future Prospects
 
01:03:52
Presented at: Cancer Research & Oncology 2017 - https://www.labroots.com/virtual-event/cancer-research-oncology-2017 Presented by: Qing Meng, PhD - Director, Department of Laboratory Medicine, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center Webinar: Circulating Tumor Cells: Clinical Utility, Challenges, and Future Prospects Abstract: The detection of CTCs has been used as useful biomarkers in prognosis and monitoring therapeutic response of patients with metastatic cancer. However, during the course of cancer therapy, CTCs have undergone epithelial-mesenchymal transition (EMT) (i.e., EMT CTCs) and the current FDA-approved technology is unable to detect such EMT CTCs. Using new technologies such as antibody against cell-surface vimentin (CSV) exclusively expressed on EMT CTCs, we are able to detect EMT CTCs from breast, colon, and prostate tumor types and monitor disease progression and predict the prognosis. This presentation will briefly review the current status of CTC detection, the detection technology and clinical utility of CTC. The challenges of the current technology and new technology in determination of CTC will be addressed. The detection of EMT CTCs especially CTC with molecular profiling for cancer diagnosis, monitoring therapeutic responses, predicting prognosis, and guiding personalized therapy will be discussed. Detection of CTCs and molecular characterization as one of the liquid biopsy approach may serve as an instrumental role for noninvasive approach in personalized cancer medicine. Earn PACE/CME Credits: 1. Make sure you’re a registered member of LabRoots - https://www.labroots.com/virtual-event/cancer-research-oncology-2017 2. Watch the webinar on YouTube above or on the LabRoots Website - https://www.labroots.com/virtual-event/cancer-research-oncology-2017 3. Click Here to get your PACE (Expiration date –October 12, 2019 09:00 AM) - http://www.labroots.com/credit/pace-credits/2482/third-party 4. Click here to get your CME credits (Expiration date – Jan. 11 2018, 6:00 A.M.) - https://www.surveymonkey.com/r/52H7TV9 LabRoots on Social: Facebook: https://www.facebook.com/LabRootsInc Twitter: https://twitter.com/LabRoots LinkedIn: https://www.linkedin.com/company/labroots Instagram: https://www.instagram.com/labrootsinc Pinterest: https://www.pinterest.com/labroots/ SnapChat: labroots_inc
Views: 106 LabRoots
'We're a team!' – it's up to you to help your doctor make the right decisions for your treatment
 
00:51
Dr Elias Jabbour, from University of Texas MD Anderson Cancer Center, Houston, talks about how important it is to work with your doctor as a team – making informed decisions together is essential. Your treatment could last a long time and a strong partnership will make your journey easier. Recorded at the American Society of Hematology (ASH) 2015 Annual Meeting, at Orlando, FL. This programme has been supported by Pfizer, through an unrestricted educational grant to the Patient Empowerment Foundation Visit our website | http://www.patientpower.eu/ Follow on Twitter | https://twitter.com/patientpowereu Like on Facebook | https://www.fb.com/patientpower.europe
Artist Kathy Ellis - Breast Cancer Interview
 
01:26
On October 18, 2012, Examiner.com columnist Gary Lindsay spoke with local Houston Artist Kathy Ellis about her Battle with Stage Four Triple-Negative Inflammatory Breast Cancer, and her treatment at the Morgan Welch Inflammatory Breast Cancer Research Center and Clinic, at MD Anderson Cancer Center in Houston, Texas. Kathy has recently published a website to sell her art to her many fans, a portion of the proceeds of which will be donated to the Morgan Welch Inflammatory Breast Cancer Research Center and Clinic, at MD Anderson Cancer Center. Visit her art website at: www.DivaWorld.biz (no longer active) Contact Kathy at: kathy@divaworld.biz (no longer active) Visit Gary's column at: www.Examiner.com/performing-arts-in-houston/gary-lindsay Contact Gary at: garylindsay.examiner@gmail.com (Update: Sadly, Kathy succumbed to her illness on Friday, August 16, 2013, but this video will be left in place so that friends and family can remember what Kathy looked and sounded like, and her courageous spirit.)
Views: 120 Gary Lindsay
Physician Communication Skills Improve  with Language of Caring
 
02:15
Physician communication skills improve with the Language of Caring. Two physicians describe how patient satisfaction and the doctor-patient relationship were enhanced at MD Anderson Cancer Center. Dr. Ronald Servi shares how LOC helps him express empathy with patients and communicate effectively with them, a challenge given the complexity of their problems. Dr. Anna Likhacheva finds LOC helps her improve confidence and relieve patient anxiety. "Once you start practicing it with patients it spills over into the co-worker environment as well." -- Anna Likhacheva, MD Visit our website http://www.languageofcaring.com to access concrete tools and resources and learn how Language of Caring programs help healthcare teams show how much they care; improve patient outcomes, CAHPS scores, and financial health; ensure patient safety; and support your organization’s mission. Sign up now for our free monthly e-newsletter HeartBeat on the Quality Patient Experience, packed with compelling insights, tips, and tools. BONUS TOOLKIT: 51 QUICK Employee Engagement Activities to Transform Your Meetings and Huddles. Just visit: http://languageofcaring.com/heartbeat-e-newsletter/
Views: 351 Language of Caring
Health Insurance: In-Network vs Out of Network
 
04:26
Rick Hasou from MD Anderson talks about seeking cancer treatment "in-network" versus "out-of-network", and co-pay verus deductible and co-insurance. What questions should you be asking your insurance provider before your first visit to a cancer center? Ricki is featured In the Spring issue of Anderson Network's newsletter, where she shares more insights into understanding health insurance during cancer treatment.
Ketogenic Diet for Brain Tumor Patients
 
01:12:44
Ketogenic Diet for Brain Tumor Patients